Risk factors for cardio-cerebrovascular events among patients undergoing continuous ambulatory peritoneal dialysis and their association with serum magnesium

References

• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. Plos One. 2016;11(7):1. doi: 10.1371/journal.pone.0158765.
   Web of Science ®Google Scholar
• Zhang L, Zhao MH, Zuo L, et al. China kidney disease network (CK-NET) 2016 annual data report. Kidney Int Suppl (2011). 2020;10(2):e97–12. doi: 10.1016/j.kisu.2020.09.001.
   PubMed Web of Science ®Google Scholar
• Bello AK, Okpechi IG, Osman MA, et al. Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol. 2022;18(12):779–793. doi: 10.1038/s41581-022-00623-7.
   PubMed Web of Science ®Google Scholar
• Andreoli MCC, Totoli C. Peritoneal dialysis. Rev Assoc Med Bras (1992). 2020;66(Suppl 1):s37–s44. doi: 10.1590/1806-9282.66.S1.37.
   Google Scholar
• Sakaguchi Y. The emerging role of magnesium in CKD. Clin Exp Nephrol. 2022;26(5):379–384. doi: 10.1007/s10157-022-02182-4.
   PubMed Web of Science ®Google Scholar
• Van Laecke S. Hypomagnesemia and hypermagnesemia. Acta Clin Belg. 2019;74(1):41–47. doi: 10.1080/17843286.2018.1516173.
   PubMed Web of Science ®Google Scholar
• Vormann J. Magnesium: nutrition and homoeostasis. AIMS Public Health. 2016;3(2):329–340. doi: 10.3934/publichealth.2016.2.329.
   PubMedGoogle Scholar
• Sakaguchi Y, Fujii N, Shoji T, et al. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85(1):174–181. doi: 10.1038/ki.2013.327.
   PubMed Web of Science ®Google Scholar
• M de Francisco AL, Rodríguez M. Magnesium - its role in CKD. Nefrologia. 2013;33(3):389–399. doi: 10.3265/Nefrologia.pre2013.Feb.11840.
   PubMed Web of Science ®Google Scholar
• Pham PC, Pham PA, Pham SV, et al. Hypomagnesemia: a clinical perspective. Int J Nephrol Renovasc Dis. 2014;7:219–230. doi: 10.2147/ijnrd.S42054.
   PubMedGoogle Scholar
• Negru AG, Pastorcici A, Crisan S, et al. The role of hypomagnesemia in cardiac arrhythmias: a clinical ­perspective. Biomedicines. 2022;10(10):2356. doi: 10.3390/biomedicines10102356.
   PubMed Web of Science ®Google Scholar
• Pethő ÁG, Tapolyai M, Browne M, et al. Hypomagnesemia as a risk factor and accelerator for vascular aging in diabetes mellitus and chronic kidney disease. Metabolites. 2023;13(2):306. doi: 10.3390/metabo13020306.
   PubMed Web of Science ®Google Scholar
• Floege J. Magnesium in CKD: more than a calcification inhibitor? J Nephrol. 2015;28(3):269–277. doi: 10.1007/s40620-014-0140-6.
   PubMed Web of Science ®Google Scholar
• Ye H, Cao P, Zhang X, et al. Serum magnesium and cardiovascular mortality in peritoneal dialysis patients: a 5-year prospective cohort study. Br J Nutr. 2018;120(4):415–423. doi: 10.1017/s0007114518001599.
   PubMed Web of Science ®Google Scholar
• Rosique-Esteban N, Guasch-Ferré M, Hernández-Alonso P, et al. Dietary magnesium and cardiovascular disease: a review with emphasis in epidemiological studies. Nutrients. 2018;10(2):168. doi: 10.3390/nu10020168.
   PubMed Web of Science ®Google Scholar
• Parent X, Spielmann C, Hanser AM. ["corrected" calcium: calcium status underestimation in non-hypoalbuminemic patients and in hypercalcemic patients]. Ann Biol Clin. 2009;67(4):411–418. doi: 10.1684/abc.2009.0348.
   PubMed Web of Science ®Google Scholar
• Ying P, Gu M, Jiang X, et al. Serum calcium-phosphorus product for predicting the risk of osteoporotic vertebral compression fractures in elderly patients: a retrospective observational study. J Orthop Surg Res. 2022;17(1):57. doi: 10.1186/s13018-022-02953-5.
   PubMed Web of Science ®Google Scholar
• Luepker RV, Lakshminarayan K. 971 Cardiovascular and cerebrovascular diseases. In: Detels R, Beaglehole R, Lansang MA, Gulliford M, editors. Oxford textbook of public health. 5th ed. Oxford: Oxford University Press, 2009. doi: 10.1093/med/9780199218707.003.0059.
   Google Scholar
• van de Wal-Visscher ER, Kooman JP, van der Sande FM. Magnesium in chronic kidney disease: should we care? Blood Purif. 2018;45(1–3):173–178. doi: 10.1159/000485212.
   PubMed Web of Science ®Google Scholar
• Lin CC, Li CI, Hsiao CY, et al. Time trend analysis of the prevalence and incidence of diagnosed type 2 diabetes among adults in Taiwan from 2000 to 2007: a population-based study. BMC Public Health. 2013;13(1):318. doi: 10.1186/1471-2458-13-318.
   PubMedGoogle Scholar
• Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296–1305. doi: 10.1056/NEJMoa041031.
   PubMed Web of Science ®Google Scholar
• Chen XT. Study on the effect of hypertension and diabetes for elderly with cardiovascular disease. Mod Prev Med. 2011;38:3253–3254.
   Google Scholar
• Xin W. The effect of arterial stiffness index for Xuzhikang capsule in patients with type 2 diabetes. Chinese J Mod Drug Appl. 2015;9:127–128.
   Google Scholar
• Barzilay JI, Spiekerman CF, Kuller LH, et al. Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the cardiovascular health study. Diabetes Care. 2001;24(7):1233–1239. doi: 10.2337/diacare.24.7.1233.
   PubMed Web of Science ®Google Scholar
• Massy ZA, Drüeke TB. Magnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival. Clin Kidney J. 2012;5(Suppl 1):i52–i61. doi: 10.1093/ndtplus/sfr167.
   PubMedGoogle Scholar
• Rodelo-Haad C, Pendón-Ruiz de Mier MV, Díaz-Tocados JM, et al. The role of disturbed Mg homeostasis in chronic kidney disease comorbidities. Front Cell Dev Biol. 2020;8:543099. doi: 10.3389/fcell.2020.543099.
   PubMed Web of Science ®Google Scholar
• Kreepala C, Luangphiphat W, Villarroel A, et al. Effect of magnesium on glomerular filtration rate and recovery of hypertension in women with severe preeclampsia. Nephron. 2018;138(1):35–41. doi: 10.1159/000481463.
   PubMed Web of Science ®Google Scholar
• Peritoneal Dialysis Adequacy Work Group. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 2006;48(Suppl 1):S98–S129. doi: 10.1053/j.ajkd.2006.04.006.
   PubMedGoogle Scholar
• Mori D, Matsui I, Shimomura A, et al. Protein carbamylation exacerbates vascular calcification. Kidney Int. 2018;94(1):72–90. doi: 10.1016/j.kint.2018.01.033.
   PubMed Web of Science ®Google Scholar
• Ray M, Jovanovich A. Mineral bone abnormalities and vascular calcifications. Adv Chronic Kidney Dis. 2019;26(6):409–416. doi: 10.1053/j.ackd.2019.09.004.
   PubMed Web of Science ®Google Scholar
• Viegas C, Araújo N, Marreiros C, et al. The interplay between mineral metabolism, vascular calcification and inflammation in chronic kidney disease (CKD): challenging old concepts with new facts. Aging. 2019;11(12):4274–4299. doi: 10.18632/aging.102046.
   PubMedGoogle Scholar
• Su CY, Lu XH, Tang W, et al. Peritoneal dialysis can maintain nitrogen balance with low Kt/V in anuric patients. Clin Nephrol. 2022;97(4):206–214. doi: 10.5414/cn110482.
   PubMed Web of Science ®Google Scholar
• Kaysen GA. Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol. 1998;9(12):2368–2376. doi: 10.1681/asn.v9122368.
   PubMed Web of Science ®Google Scholar
• Lacson E, Jr., Wang W, Ma L, et al. Serum magnesium and mortality in hemodialysis patients in the United States: a cohort study. Am J Kidney Dis. 2015;66(6):1056–1066. doi: 10.1053/j.ajkd.2015.06.014.
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9(1):69. doi: 10.1186/1475-2891-9-69.
   PubMed Web of Science ®Google Scholar
• Das UN. Albumin to globulin ratio and/or plasma albumin in predicting long-term mortality. Am J Surg. 2014;208(1):157–158. doi: 10.1016/j.amjsurg.2013.08.055.
   PubMed Web of Science ®Google Scholar
• Wu PP, Hsieh YP, Kor CT, et al. Association between albumin-Globulin ratio and mortality in patients with chronic kidney disease. J Clin Med. 2019;8(11):1991. doi: 10.3390/jcm8111991.
   PubMed Web of Science ®Google Scholar
• Kaneko S, Ookawara S, Morishita Y. Clinical factors associated with serum magnesium concentration in patients undergoing peritoneal dialysis: a Single-Center observational study. Int J Nephrol Renovasc Dis. 2022;15:185–195. doi: 10.2147/ijnrd.S357130.
   PubMed Web of Science ®Google Scholar
• Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199–8226. doi: 10.3390/nu7095388.
   PubMed Web of Science ®Google Scholar
• Davies SJ, Zhao J, Morgenstern H, et al. Low serum potassium levels and clinical outcomes in peritoneal dialysis-international results from PDOPPS [published correction appears in kidney int rep. 2021 Mar 11;6(5):1485]Kidney Int Rep. 2021;6(2):313–324. doi: 10.1016/j.ekir.2020.11.021.
   PubMed Web of Science ®Google Scholar
• Saito Y, Tanaka A, Node K, et al. Uric acid and cardiovascular disease: a clinical review. J Cardiol. 2021;78(1):51–57. doi: 10.1016/j.jjcc.2020.12.013.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Titte S, Cade JR, et al. Uric acid, evolution and primitive cultures. Semin Nephrol. 2005;25(1):3–8. doi: 10.1016/j.semnephrol.2004.09.002.
   PubMed Web of Science ®Google Scholar
• Bos MJ, Koudstaal PJ, Hofman A, et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke. 2006;37(6):1503–1507. doi: 10.1161/01.STR.0000221716.55088.d4.
   PubMed Web of Science ®Google Scholar
• Rock KL, Kataoka H, Lai JJ. Uric acid as a danger signal in gout and its comorbidities. Nat Rev Rheumatol. 2013;9(1):13–23. doi: 10.1038/nrrheum.2012.143.
   PubMed Web of Science ®Google Scholar
• Zhao G, Huang L, Song M, et al. Baseline serum uric acid level as a predictor of cardiovascular disease related mortality and all-cause mortality: a meta-analysis of prospective studies. Atherosclerosis. 2013;231(1):61–68. doi: 10.1016/j.atherosclerosis.2013.08.023.
   PubMed Web of Science ®Google Scholar
• Kleber ME, Delgado G, Grammer TB, et al. Uric acid and cardiovascular events: a mendelian randomization study. J Am Soc Nephrol. 2015;26(11):2831–2838. doi: 10.1681/asn.2014070660.
   PubMed Web of Science ®Google Scholar
• Deng X, Gao B, Wang F, et al. Red blood cell distribution width is associated with adverse kidney outcomes in patients with chronic kidney disease. Front Med. 2022;9:877220. doi: 10.3389/fmed.2022.877220.
   Google Scholar
• Chen J, Li Y, Liu P, et al. A nomogram to predict the in-hospital mortality of patients with congestive heart failure and chronic kidney disease. ESC Heart Fail. 2022;9(5):3167–3176. doi: 10.1002/ehf2.14042.
   PubMed Web of Science ®Google Scholar
• Allen LA, Felker GM, Mehra MR, et al. Validation and potential mechanisms of red cell distribution width as a prognostic marker in heart failure. J Card Fail. 2010;16(3):230–238. doi: 10.1016/j.cardfail.2009.11.003.
   PubMed Web of Science ®Google Scholar
• Tomaiuolo G, Lanotte L, D’Apolito R, et al. Microconfined flow behavior of red blood cells. Med Eng Phys. 2016;38(1):11–16. doi: 10.1016/j.medengphy.2015.05.007.
   PubMed Web of Science ®Google Scholar
• Reinhart WH, Piety NZ, Goede JS, et al. Effect of osmolality on erythrocyte rheology and perfusion of an ­artificial microvascular network. Microvasc Res. 2015;98:102–107. doi: 10.1016/j.mvr.2015.01.010.
   PubMed Web of Science ®Google Scholar
• Ritz E, Dikow R, Adamzcak M, et al. Congestive heart failure due to systolic dysfunction: the Cinderella of cardiovascular management in dialysis patients. Semin Dial. 2002;15(3):135–140. doi: 10.1046/j.1525-139x.2002.00044.x.
   PubMed Web of Science ®Google Scholar
• Gunal AI, Karaca I, Aygen B, et al. Strict fluid volume control and left ventricular hypertrophy in ­hypertensive patients on chronic haemodialysis: a cross-sectional study. J Int Med Res. 2004;32(1):70–77. doi: 10.1177/147323000403200112.
   PubMed Web of Science ®Google Scholar
• Romanovsky A, Bagshaw S, Rosner MH. Hyponatremia and congestive heart failure: a marker of increased mortality and a target for therapy. Int J Nephrol. 2011;2011:732746–732747. doi: 10.4061/2011/732746.
   PubMedGoogle Scholar
• Kataoka H. Proposal for heart failure progression based on the ‘chloride theory’: worsening heart failure with increased vs. non-increased serum chloride concentration. ESC Heart Fail. 2017;4(4):623–631. doi: 10.1002/ehf2.12191.
   PubMed Web of Science ®Google Scholar
• Adkins GB, Curtis MJ. Potential role of cardiac chloride channels and transporters as novel therapeutic targets. Pharmacol Ther. 2015;145:67–75. doi: 10.1016/j.pharmthera.2014.08.002.
   PubMed Web of Science ®Google Scholar
• Cuthbert JJ, Pellicori P, Rigby A, et al. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance. Eur J Heart Fail. 2018;20(10):1426–1435. doi: 10.1002/ejhf.1247.
   PubMed Web of Science ®Google Scholar
• Kazory A, Ronco C. Emergence of chloride as an overlooked cardiorenal connector in heart failure. Blood Purif. 2020;49(1-2):219–221. doi: 10.1159/000503774.
   PubMed Web of Science ®Google Scholar
• Maynard N, Bihari D, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993;270(10):1203–1210. doi: 10.1001/jama.1993.03510100053032.
   PubMed Web of Science ®Google Scholar
• Testani JM, Hanberg JS, Arroyo JP, et al. Hypochloraemia is strongly and independently associated with mortality in patients with chronic heart failure. Eur J Heart Fail. 2016;18(6):660–668. doi: 10.1002/ejhf.477.
   PubMed Web of Science ®Google Scholar